Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorCastro Marrero, Jesus
dc.contributor.authorZaragozá, Maria-Cleofé
dc.contributor.authorLópez-Vílchez, Irene
dc.contributor.authorGalmés, José Luis
dc.contributor.authorCordobilla, Begoña
dc.contributor.authorMaurel Ibáñez, Sara Nieves
dc.contributor.authorAlegre Martin, José
dc.date.accessioned2022-03-23T12:07:36Z
dc.date.available2022-03-23T12:07:36Z
dc.date.issued2021-07
dc.identifier.citationCastro-Marrero J, Zaragozá MC, López-Vílchez I, Galmés JL, Cordobilla B, Maurel S, et al. Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Antioxidants. 2021 Jul;10(7):1010.
dc.identifier.issn2076-3921
dc.identifier.urihttps://hdl.handle.net/11351/7253
dc.descriptionSíndrome de fatiga crònica; Melatonina; Encefalomielitis miàlgica
dc.description.sponsorshipJ.C.-M. received financial support from the Laboratorios Viñas, S.A. (Barcelona, Spain). This study was supported by the Vall d’Hebron University Hospital (Barcelona, Spain). The Laboratorios Viñas, S.A. supplied both treatments (melatonin plus zinc supplement and placebo).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesAntioxidants;10(7)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectSíndrome de fatiga crònica - Tractament
dc.subjectSuplements nutritius - Ús terapèutic - Eficàcia
dc.subjectEncefalomielitis - Tractament
dc.subject.meshDouble-Blind Method
dc.subject.meshFatigue Syndrome, Chronic
dc.subject.mesh/drug therapy
dc.subject.meshDietary Supplements
dc.titleEffect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/antiox10071010
dc.subject.decsmétodo doble ciego
dc.subject.decssíndrome de fatiga crónica
dc.subject.decs/farmacoterapia
dc.subject.decssuplementos dietéticos
dc.relation.publishversionhttps://doi.org/10.3390/antiox10071010
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Castro-Marrero J] Servei de Reumatologia, Unitat de Encefalomielitis Miàlgica/Síndrome de Fatiga Crònica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Zaragozá MC, López-Vílchez I, Galmés JL] Clinical Research Department, Laboratorios Viñas, 08012 Barcelona, Spain. [Cordobilla B] Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, 08028 Barcelona, Spain. [Maurel S] Department of Neurosciences, University of the Basque Country, 48940 Leioa, Spain. [Alegre-Martín J] Servei de Reumatologia, Unitat de Encefalomielitis Miàlgica/Síndrome de Fatiga Crònica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid34201806
dc.identifier.wos000675980500001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Portada del document

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple